Key result
F-HARP model identifies acute PE patients with ~3.2-fold higher major bleeding odds after CDT.
Why the study?
Catheter-directed thrombolysis is an established reperfusion strategy for intermediate- or high-risk acute pulmonary embolism, yet no validated model existed to predict early major bleeding in this population.
Does the F-HARP baseline risk assessment model predict early major bleeding in patients undergoing catheter-directed thrombolysis for acute pulmonary embolism?
Cohort (n=1,812)
Yes
Does the F-HARP baseline risk assessment model predict early major bleeding in patients undergoing catheter-directed thrombolysis for acute pulmonary embolism?
The F-HARP model utilizes four readily available baseline variables (Female sex, Hypertension, Age, high-Risk PE) to identify patients at a three-fold higher odds of major bleeding following catheter-directed thrombolysis for acute pulmonary embolism.
Answers are grounded in this paper and cite their sources.
May guide bleeding risk stratification before catheter-directed thrombolysis for pulmonary embolism; leaves open prospective validation of the F-HARP model.
BACKGROUND: Catheter-directed thrombolysis is an established reperfusion strategy for intermediate- or high-risk acute pulmonary embolism. No validated model exists to predict early major bleeding in this population. OBJECTIVES: To derive a baseline-only risk assessment model for major bleeding after catheter-directed thrombolysis, and to assess its transferability in an independent cohort. PATIENTS/METHODS: We pooled patient-level data from 16 cohort studies and randomized trials of catheter-directed thrombolysis for acute pulmonary embolism. The most stable baseline predictors of major bleeding were identified by adaptive LASSO across 1000 bootstrap iterations. Candidate models including 2 to 6 of these predictors were compared on optimism-corrected discrimination and calibration. The selected model was applied to an independent cohort from the RIETE registry. RESULTS: Of 1246 patients with outcome data and without contraindications to thrombolysis, 75 (6.0%) experienced major bleeding, including 10 intracranial hemorrhages. On internal validation, the F-HARP model (Female sex, Hypertension, Age, high-Risk Pulmonary embolism) showed an optimism-corrected area under the receiver operating characteristic curve (AUROC) of 0.695 (95%CI: 0.639-0.755). In the independent cohort (N=566), patients classified as high risk had higher odds of major bleeding within 30 days than the remainder (11.2% vs. 3.8%; OR 3.18, 95%CI: 1.44-7.05). AUROC was 0.638 (95%CI: 0.519-0.742) and calibration slope 0.630 (95%CI: 0.153-1.107). CONCLUSIONS: The F-HARP model uses four readily available baseline predictors to identify a subgroup at meaningfully higher odds of major bleeding after catheter-directed thrombolysis. A powered external validation is required prior to its use for precise risk quantification.
No takes yet. Share an insight, caveat, or question.
Tsaftaridis et al. (2026) conducted a cohort in Acute pulmonary embolism treated with catheter-directed thrombolysis (n=1,812). F-HARP model high-risk classification (Female sex, Hypertension, Age, high-Risk Pulmonary embolism) vs. Non-high-risk classification by the F-HARP model was evaluated on Major bleeding within 30 days (OR 3.18, 95% CI 1.44-7.05). The F-HARP risk model identified high-risk acute PE patients with higher 30-day major bleeding odds after catheter-directed thrombolysis.
Synapse has enriched 10 related papers. Consider them for comparative context: